Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
The current Zoetis(ZTS) stock price is $124.09, with a market capitalization of 54.68B. The stock trades at a price-to-earnings (P/E) ratio of 20.60 and offers a dividend yield of 1.6%.
As of 2025-12-18, Zoetis(ZTS) stock has fluctuated between $122.01 and $125.53. The current price stands at $124.09, placing the stock +1.7% above today's low and -1.2% off the high.
Zoetis(ZTS) shares are trading with a volume of 4.78M, against a daily average of 6.97M.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $177.40 and a 52-week low of $115.25.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $177.40 and a 52-week low of $115.25.
ZTS News
Morgan Stanley lowered the firm’s price target on Zoetis (ZTS) to $160 from $175 and keeps an Overweight rating on the shares. For healthcare technology and pro...
For investors wondering if Zoetis is starting to look like a bargain after a rough stretch, this is the kind of setup where a deeper valuation check can help un...
Key Points One is a sector mainstay that has now raised its payout 17 years in a row. The other is a big player in the animal healthcare space. It's not too...
Analyst ratings
68%
of 22 ratingsMore ZTS News
Zoetis (ZTS) stock rose over 2% on Monday after the animal health giant disclosed plans to raise $1.75 billion through a private offering of convertible senior...
Zoetis (ZTS) just packed a lot into a short stretch, from showcasing a fuller innovation pipeline to lifting its dividend and winning Canadian approval for a ne...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Zoetis Inc. recently announced that Health Canada has approved Portela (relfovetmab injection), a monoclonal antibody designed to provide three months of osteoa...